The Consensus from the Mycobacterium avium ssp. paratuberculosis (MAP) Conference 2017

Multiple other attendees at MAP Consensus Conference, Temple University, Philadelphia, March 2017

Research output: Contribution to journalComment/debatepeer-review

49 Citations (Scopus)
665 Downloads (Pure)


On March 24 and 25, 2017, researchers and clinicians from around the world met at Temple University in Philadelphia to discuss the current knowledge of Mycobacterium avium ssp. paratuberculosis (MAP) and its relationship to human disease. The conference was held because of shared concern that MAP is a zoonotic bacterium that poses a threat not only to animal health but also human health. In order to further study this problem, the conferees discussed ways to improve MAP diagnostic tests and discussed potential future anti-MAP clinical trials. The conference proceedings may be viewed on the website. A summary of the salient work in this field is followed by recommendations from a majority of the conferees.
Original languageEnglish
Article number208
Number of pages5
JournalFrontiers in public health
Publication statusPublished - 26 Sep 2017


  • Mycobacterium avium subspecies paratuberculosis, crohn’s disease, zoonosis and health public, 084 Johne’s disease, type i diabetes, complex regional pain syndrome, lymphangiomatosis


Dive into the research topics of 'The Consensus from the Mycobacterium avium ssp. paratuberculosis (MAP) Conference 2017'. Together they form a unique fingerprint.

Cite this